<DOC>
	<DOCNO>NCT00210743</DOCNO>
	<brief_summary>The purpose study evaluate hemoglobin response rate subject anemia , associate chronic kidney failure , receive epoetin alfa ( PROCRITÂ® ) every 2 week</brief_summary>
	<brief_title>Alternate Dosing - Initiation Every 2 Week Epoetin Alfa ( PROCRIT ) Treatment Anemia .</brief_title>
	<detailed_description>This prospective study non-dialysis subject anemia associate chronic kidney disease . Subjects enrol multiple center United States . The primary objective study evaluate hemoglobin response rate . The secondary objective include evaluate time hemoglobin responds , indicate result hemoglobin blood level , change hemoglobin time , transfusion requirement change quality life measurement . These measurement ask subject view one feel , activity energy level , etc . The subject administer study drug every 2 week Study Week 27 unless dose hold subject withdraws study . Each injection study drug exceed 1 ml volume .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Subjects chronic kidney disease glomerular filtration rate within 1060 ml/min/1.73m2 expect need dialysis study subject hemoglobin less 11 g/dL subject receive erythropoietic agent within 6 week study entry female subject , reproductive potential , must negative urine pregnancy test within 7 day first dose study drug . Subjects poorly control high blood pressure ( hypertension ) systolic &gt; 150 mm Hg diastolic &gt; 100 mm Hg know hypersensitivity human albumin and/or mammalian cellderived product subject receive dialysis subject ferritin level &lt; 50 ng/mL , Transferrin Saturation &lt; 20 % subject receive chemotherapy cancer within 1 month prior study start expect study participation Pregnancy lactation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Anemia</keyword>
	<keyword>chronic kidney disease</keyword>
	<keyword>erythropoetin , Epoetin alfa</keyword>
	<keyword>erythropoetin recombinant</keyword>
	<keyword>pre-dialysis</keyword>
</DOC>